Fairvalue-Calculator Fairvalue-Calculator
EN DE

Metall Zug AG (MTLZF) Fair Value & Analysis

Healthcare · US · Market cap $682M

Price$1,526
Fair Value$1,261
Upside-17.4%
Quality81/100
Evidence: Low Range $940.90 – $1,882

Analysis

Metall Zug AG (MTLZF) currently trades at $1,526, while our model-based Fair Value estimate is $1,261 — implying the stock looks roughly 17.4% overvalued today. We read business quality at 81/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Metall Zug AG, through its subsidiaries, engages in the medical devices, infection control, technology cluster and infrastructure, and other businesses in Switzerland, Europe, North America, South America, the Asia Pacific, and internationally. The company develops, manufactures, and distributes devices and solutions for medical diagnosis, microsurgery, and eye training. It also offers diagnostics equipment, such as slit lamps, tonometry devices, and perimetry and biometry equipment for cataract diagnosis and treatment; equipment for ophthalmologists, including tables, chairs, and industrial high-precision surgical microscopes; accessories, including measuring instruments for precision optics, lenses, software solutions, and comprehensive services; and augmented and virtual reality technology and digital imaging for the training and further education of eye care specialists. In addition, the company supplies dishwashers, thermal appliances, and cleaning agents for catering and hotel…

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABTT34) -84% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -83% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +11%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.